FDA Inspection 1315858 — Amy T. Waldman, MD, MSCE
The FDA completed an inspection of Amy T. Waldman, MD, MSCE on April 24, 2026 in Philadelphia, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 24, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Philadelphia, PA (United States)
Additional Details
Clinical Investigator (CI)